Published in J Mol Cell Cardiol on October 04, 2007
Requirement of protein kinase D1 for pathological cardiac remodeling. Proc Natl Acad Sci U S A (2008) 2.12
Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cycling. J Biol Chem (2009) 1.47
cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies. Br J Pharmacol (2009) 1.25
Compartmentalization of beta-adrenergic signals in cardiomyocytes. Circ Res (2011) 1.07
Revisited and revised: is RhoA always a villain in cardiac pathophysiology? J Cardiovasc Transl Res (2010) 1.05
Protein kinase D isoforms are expressed in rat and mouse primary sensory neurons and are activated by agonists of protease-activated receptor 2. J Comp Neurol (2009) 0.94
The role of nitric oxide and reactive oxygen species in the positive inotropic response to mechanical stretch in the mammalian myocardium. Biochim Biophys Acta (2009) 0.90
Regulation by phosphodiesterase isoforms of protein kinase A-mediated attenuation of myocardial protein kinase D activation. Basic Res Cardiol (2010) 0.89
Novel function of cardiac protein kinase D1 as a dynamic regulator of Ca2+ sensitivity of contraction. J Biol Chem (2010) 0.86
β-Adrenergic receptor stimulation and activation of protein kinase A protect against α1-adrenergic-mediated phosphorylation of protein kinase D and histone deacetylase 5. J Card Fail (2011) 0.85
Myocardial adenosine A(1)-receptor-mediated adenoprotection involves phospholipase C, PKC-epsilon, and p38 MAPK, but not HSP27. Am J Physiol Heart Circ Physiol (2010) 0.83
Histone deacetylase signaling in cardioprotection. Cell Mol Life Sci (2013) 0.80
Na⁺/H⁺ exchangers and intracellular pH in perinatal brain injury. Transl Stroke Res (2014) 0.79
Four-and-a-half LIM domains proteins are novel regulators of the protein kinase D pathway in cardiac myocytes. Biochem J (2014) 0.79
Crosstalk between adenosine A1 and β1-adrenergic receptors regulates translocation of PKCε in isolated rat cardiomyocytes. J Cell Physiol (2012) 0.78
Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling. Proc Natl Acad Sci U S A (2014) 0.78
β-adrenergic signaling inhibits Gq-dependent protein kinase D activation by preventing protein kinase D translocation. Circ Res (2014) 0.77
β-Adrenergic Stimulation Induces Histone Deacetylase 5 (HDAC5) Nuclear Accumulation in Cardiomyocytes by B55α-PP2A-Mediated Dephosphorylation. J Am Heart Assoc (2017) 0.75
Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science (2007) 3.29
Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function. Circ Res (2004) 2.44
Activation of p38 mitogen-activated protein kinase contributes to the early cardiodepressant action of tumor necrosis factor. J Am Coll Cardiol (2006) 1.89
Protein kinase B/Akt phosphorylates and inhibits the cardiac Na+/H+ exchanger NHE1. Circ Res (2008) 1.85
Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. Circ Res (2013) 1.81
A critical function for Ser-282 in cardiac Myosin binding protein-C phosphorylation and cardiac function. Circ Res (2011) 1.61
Protein kinase d in the cardiovascular system: emerging roles in health and disease. Circ Res (2008) 1.59
Ca2+/calmodulin-dependent protein kinase IIdelta and protein kinase D overexpression reinforce the histone deacetylase 5 redistribution in heart failure. Circ Res (2008) 1.58
Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cycling. J Biol Chem (2009) 1.47
Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ Res (2008) 1.44
Protein kinase D selectively targets cardiac troponin I and regulates myofilament Ca2+ sensitivity in ventricular myocytes. Circ Res (2007) 1.43
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2011) 1.40
Development of the human pancreas from foregut to endocrine commitment. Diabetes (2013) 1.21
Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice. J Mol Cell Cardiol (2012) 1.13
Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent. Nat Med (2011) 1.13
Activation of heterotrimeric G proteins by a high energy phosphate transfer via nucleoside diphosphate kinase (NDPK) B and Gbeta subunits. Specific activation of Gsalpha by an NDPK B.Gbetagamma complex in H10 cells. J Biol Chem (2002) 1.08
A novel role for protein phosphatase 2A in receptor-mediated regulation of the cardiac sarcolemmal Na+/H+ exchanger NHE1. J Biol Chem (2006) 1.08
Novel role for p90 ribosomal S6 kinase in the regulation of cardiac myofilament phosphorylation. J Biol Chem (2010) 1.05
Stimulation of the plasma membrane Na+/H+ exchanger NHE1 by sustained intracellular acidosis. Evidence for a novel mechanism mediated by the ERK pathway. J Biol Chem (2003) 1.05
Proteomics analysis of the cardiac myofilament subproteome reveals dynamic alterations in phosphatase subunit distribution. Mol Cell Proteomics (2009) 1.04
Targeting Na+/H+ exchanger regulation for cardiac protection: a RSKy approach? Curr Opin Pharmacol (2008) 1.03
Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy. J Mol Cell Cardiol (2010) 1.02
cMyBP-C as a promiscuous substrate: phosphorylation by non-PKA kinases and its potential significance. J Muscle Res Cell Motil (2011) 0.99
Neurohormonal regulation of cardiac histone deacetylase 5 nuclear localization by phosphorylation-dependent and phosphorylation-independent mechanisms. Circ Res (2012) 0.98
LRIG2 mutations cause urofacial syndrome. Am J Hum Genet (2013) 0.97
A chemical genetic approach reveals that p38alpha MAPK activation by diphosphorylation aggravates myocardial infarction and is prevented by the direct binding of SB203580. J Biol Chem (2009) 0.96
Effects of bisindolylmaleimide PKC inhibitors on p90RSK activity in vitro and in adult ventricular myocytes. Br J Pharmacol (2005) 0.90
Regulation of sarcolemmal Na(+)/H(+) exchange by hydrogen peroxide in adult rat ventricular myocytes. Cardiovasc Res (2002) 0.90
Evidence for an intracellular localization of the adenosine A2B receptor in rat cardiomyocytes. Basic Res Cardiol (2011) 0.90
Regulation by phosphodiesterase isoforms of protein kinase A-mediated attenuation of myocardial protein kinase D activation. Basic Res Cardiol (2010) 0.89
Phospholemman Ser69 phosphorylation contributes to sildenafil-induced cardioprotection against reperfusion injury. Am J Physiol Heart Circ Physiol (2010) 0.88
Paradoxical resistance to myocardial ischemia and age-related cardiomyopathy in NHE1 transgenic mice: a role for ER stress? J Mol Cell Cardiol (2008) 0.87
Inhibition of the Na+/H+ exchanger attenuates the deterioration of ventricular function during pacing-induced heart failure in rabbits. Cardiovasc Res (2004) 0.86
Phosphoregulation of the titin-cap protein telethonin in cardiac myocytes. J Biol Chem (2013) 0.85
Specificity of action of bisindolylmaleimide protein kinase C inhibitors: do they inhibit the 70kDa ribosomal S6 kinase in cardiac myocytes? Biochem Pharmacol (2004) 0.84
Ca(2+)/calmodulin-dependent protein kinase II contributes to intracellular pH recovery from acidosis via Na(+)/H(+) exchanger activation. J Mol Cell Cardiol (2009) 0.84
Urofacial syndrome: a genetic and congenital disease of aberrant urinary bladder innervation. Pediatr Nephrol (2013) 0.84
Cardioprotective efficacy of zoniporide, a potent and selective inhibitor of Na+/H+ exchanger isoform 1, in an experimental model of cardiopulmonary bypass. Br J Pharmacol (2004) 0.83
Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms. J Physiol (2014) 0.82
Distinct signaling pathways mediate cardiomyocyte phospholipase D stimulation by endothelin-1 and thrombin. J Mol Cell Cardiol (2002) 0.81
Ras triggers acidosis-induced activation of the extracellular-signal-regulated kinase pathway in cardiac myocytes. Biochem J (2006) 0.81
Inhibition of angiotensin-converting enzyme reduces susceptibility of hypertrophied rat myocardium to ventricular fibrillation. Circ J (2002) 0.79
Four-and-a-half LIM domains proteins are novel regulators of the protein kinase D pathway in cardiac myocytes. Biochem J (2014) 0.79
Translating molecular target into drug therapy in cardiovascular disease. Curr Opin Pharmacol (2008) 0.78
Influence of isoprostane F2alpha-III on reflow after myocardial infarction. Eur Heart J (2004) 0.78
Susceptibility to ischemia and reperfusion arrhythmias in myocardial hypertrophy: due to flow of injury current? Jpn Heart J (2003) 0.78
Heart failure-specific changes in protein kinase signalling. Pflugers Arch (2014) 0.78
Na+/H+ exchange inhibition in hypertrophied myocardium subjected to cardioplegic arrest: an effective cardioprotective approach. Eur J Cardiothorac Surg (2005) 0.77
Feeling the stress: MAPKKK-MAPKK-MAPK signaling cascades in heart failure. J Mol Cell Cardiol (2009) 0.77
Urotensin II activates sarcolemmal Na+/H+ exchanger in adult rat ventricular myocytes. J Cardiovasc Pharmacol (2010) 0.76
The ERK pathway regulates Na(+)-HCO(3)(-) cotransport activity in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol (2002) 0.76
The salt of the earth: focus on Na⁺ regulation in the cardiac myocyte. J Mol Cell Cardiol (2013) 0.75
Experimental studies on myocardial protection with intermittent cross-clamp fibrillation: additive effect of the sodium-hydrogen exchanger inhibitor, cariporide. Ann Thorac Surg (2004) 0.75
Left and right coronary circulation in left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition. Circ J (2002) 0.75